RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex

Genes and Development

Volumn 30, Issue 4, 2016, Pages 460-470

  Estrella, Michael A ^a   Kuo, Fang Ting ^a   Bailey, Scott ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

CMR; CRISPR Cas; Nuclease; RAMP; RNA

Indexed keywords

ASPARTIC ACID; BACTERIAL PROTEIN; CMR2 PROTEIN; DEOXYRIBONUCLEASE; DNA; HISTIDINE; RNA; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; BACTERIAL RNA; PROTEIN BINDING;

ARTICLE; BACTERIAL GENOME; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA CLEAVAGE; DNA TRANSCRIPTION; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; RNA BINDING; THERMOTOGA MARITIMA; ENZYME ACTIVATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

BACTERIAL PROTEINS; CRISPR-CAS SYSTEMS; DEOXYRIBONUCLEASES; DNA CLEAVAGE; ENZYME ACTIVATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, BACTERIAL; THERMOTOGA MARITIMA;

EID: 84958974597     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.273722.115     Document Type: Article

References (47)

1. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709-1712.
2. Benda C, Ebert J, Scheltema RA, Schiller HB, Baumgärtner M, Bonneau F, Mann M, Conti E. 2014. Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4. Mol Cell 56: 43-54.
3. Bolotin A. 2005. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151: 2551-2561.
4. Brouns SJJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJH, Snijders APL, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. 2008. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960-964.
5. Carte J, Wang R, Li H, Terns R, Terns M. 2008. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev 22: 3489-3496.
6. Cocozaki AI, RamiaNF, ShaoY, Hale CR, Terns R, Terns M, Li H. 2012. Structure of the Cmr2 subunit of the CRISPR-Cas RNA silencing complex. Structure 20: 545-553.
7. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E. 2011. CRISPR RNA maturation by trans-encoded smallRNA and host factor RNase III. Nature 471: 602-607.
8. Deng L, Garrett RA, Shah SA, Peng X, She Q. 2013. A novel interference mechanism by a Type IIIB CRISPR-Cmr module in Sulfolobus. Mol Microbiol 87: 1088-1099.
9. Garneau JE, Dupuis M-È, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S. 2010. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468: 67-71.
10. Garrett R, Shah S, Erdmann S, Liu G, Mousaei M, León-Sobrino C, Peng W, Gudbergsdottir S, Deng L, Vestergaard G, et al. 2015. CRISPR-Cas adaptive immune systems of the sulfolobales: unravelling their complexity and diversity. Life (Basel) 5: 783-817.
11. Gasiunas G, Barrangou R, Horvath P, Siksnys V. 2012. Cas9- crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci 109: E2579-E2586.
12. GoldbergGW, JiangW, Bikard D, Marraffini LA. 2014. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514: 633-637.
13. Hale CR, Zhao P, Olson S, Duff MO, Graveley BR,Wells L, Terns R, Terns M. 2009. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139: 945-956.
14. Hale CR, Majumdar S, Elmore J, Pfister N, Compton M, Olson S, Resch AM, Glover CVC III, Graveley BR, Terns R, et al. 2012. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol Cell 45: 292-302.
15. Hale CR, Cocozaki A, Li H, Terns R, Terns M. 2014. Target RNA capture and cleavage by the CmrType III-B CRISPR-Cas effector complex. Genes Dev 28: 2432-2443.
16. Hatoum-Aslan A, Maniv I, Samai P, Marraffini LA. 2014. Genetic characterization of antiplasmid immunity through a Type IIIA CRISPR-Cas system. J Bacteriol 196: 310-317.
17. Huang Z, Szostak JW. 1996. A simple method for 3′-labeling of RNA. Nucleic Acids Res 24: 4360-4361.
18. Huber R, Langworthy TA, König H, ThommM,Woese CR, Sleytr UB, Stetter KO. 1986. Thermotoga maritima sp. nov. represents a new genus of unique extremely thermophilic eubacteria growing up to 90°C. Arch Microbiol 144: 324-333.
19. Jackson RN, Wiedenheft B. 2015. A conserved structural chassis for mounting versatile CRISPR RNA-guided immune responses. Mol Cell 58: 722-728.
20. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
21. Jung T-Y, An Y, Park K-H, Lee M-H, Oh B-H,Woo E. 2015. Crystal structure of the Csm1 subunit of the Csm complex and its single- stranded DNA-specific nuclease activity. Structure 23: 782-790.
22. Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Horvath P, Moineau S, Mojica FJM, Wolf YI, Yakunin AF, et al. 2011. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9: 467-477.
23. Makarova KS, Anantharaman V, Aravind L, Koonin EV. 2012. Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes. Biol Direct 7: 40.
24. Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJJ, Charpentier E, Haft DH, et al. 2015. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13: 722-736.
25. Marraffini LA, Sontheimer EJ. 2010. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463: 568-571.
26. Mojica FJM, Díez-Villaseñor CS, García-Martínez J, Soria E. 2005. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60: 174-182.
27. Mulepati S, Bailey S. 2011. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3). J Biol Chem 286: 31896-31903.
28. Mulepati S, Bailey S. 2013. In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target. J Biol Chem 288: 22184-22192.
29. Osawa T, Inanaga H, Sato C, Numata T. 2015. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Mol Cell 58: 418-430.
30. Peränen J, Rikkonen M, Hyvönen M, Kääriäinen L. 1996. T7 vectors with a modified T7lac promoter for expression of proteins in Escherichia coli. Anal Biochem 236: 371-373.
31. Pourcel C. 2005. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151: 653-663.
32. Ramia NF, Spilman M, Tang L, Shao Y, Elmore J, Hale C, Cocozaki A, Bhattacharya N, Terns R, Terns M, et al. 2014a. Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep 9: 1610-1617.
33. Ramia NF, Tang L, Cocozaki AI, Li H. 2014b. Staphylococcus epidermidis Csm1 is a 3′-5′ exonuclease. Nucleic Acids Res 42: 1129-1138.
34. Rouillon C, Zhou M, Zhang J, Politis A, Beilsten-Edmands V, Cannone G, Graham S, Robinson CV, Spagnolo L, White MF. 2013. Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol Cell 52: 124-134.
35. Samai P, Pyenson N, Jiang W, Goldberg GW, Hatoum-Aslan A, Marraffini LA. 2015. Co-transcriptionalDNAand RNA cleavage during Type III CRISPR-Cas immunity. Cell 161: 1164-1174.
36. Sinkunas T, Gasiunas G, Waghmare SP, Dickman MJ, Barrangou R, Horvath P, Siksnys V. 2013. In vitro reconstitution of Cascade- mediated CRISPR immunity in Streptococcus thermophilus. EMBO J 32: 385-394.
37. Spilman M, Cocozaki A, Hale C, Shao Y, Ramia N, Terns R, Terns M, Li H, Stagg S. 2013. Structure of anRNAsilencing complex of the CRISPR-Cas immune system. Mol Cell 52: 146-152.
38. Staals RHJ, Agari Y, Maki-Yonekura S, Zhu Y, Taylor DW, van Duijn E, Barendregt A, Vlot M, Koehorst JJ, Sakamoto K, et al. 2013. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol Cell 52: 135-145.
39. Staals RHJ, Zhu Y, TaylorDW, Kornfeld JE, Sharma K, Barendregt A, Koehorst JJ, Vlot M, Neupane N, Varossieau K, et al. 2014. RNA targeting by the Type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol Cell 56: 518-530.
40. Tamulaitis G, Kazlauskiene M, Manakova E, Venclovas Cˇ , Nwokeoji AO, Dickman MJ, Horvath P, Siksnys V. 2014. Programmable RNA shredding by the Type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol Cell 56: 506-517.
41. Taylor DW, Zhu Y, Staals RHJ, Kornfeld JE, Shinkai A, van der Oost J, Nogales E, Doudna JA. 2015. Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning. Science 348: 581-585.
42. van der Oost J, Westra ER, Jackson RN, Wiedenheft B. 2014. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol 12: 479-492.
43. Wang D, Landick R. 1997. Nuclease cleavage of the upstreamhalf of the nontemplate strand DNA in an Escherichia coli transcription elongation complex causes upstream translocation and transcriptional arrest. J Biol Chem 272: 5989-5994.
44. Westra ER, van Erp PBG, Künne T, Wong SP, Staals RHJ, Seegers CLC, Bollen S, JoreMM,Semenova E, Severinov K, et al. 2012. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell 46: 595-605.
45. ZebecZ,ManicaA,ZhangJ,WhiteMF, Schleper C. 2014. CRISPRmediated targetedmRNAdegradation in the archaeon Sulfolobus solfataricus. Nucleic Acids Res 42: 5280-5288.
46. Zhang J, Rouillon C, Kerou M, Reeks J, Brugger K, Graham S, Reimann J, Cannone G, Liu H, Albers S-V, et al. 2012. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell 45: 303-313.
47. Zhu X, Ye K. 2015. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex. Nucleic Acids Res 43: 1257-1267.